Daemen, T <br/><br/>
Immunization strategy against cervical cancer involving an alphavirus vector expressing high levels of a stable fusion protein of human papillomavirus 16 E6 and E7.  [electronic resource] 

 -  Gene therapy  Jan 2002 
 - 85-94 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0969-7128 
<br/><br/><label>Standard No.: </label>10.1038/sj.gt.3301627  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Blotting, Western<br/>Cancer Vaccines--immunology<br/>Cell Line<br/>Cricetinae<br/>Cytotoxicity, Immunologic<br/>Female<br/>Genetic Vectors--immunology<br/>Immunization--methods<br/>Mice<br/>Mice, Inbred C57BL<br/>Neoplasm Transplantation<br/>Oncogene Proteins, Viral--genetics<br/>Papillomaviridae--genetics<br/>Papillomavirus E7 Proteins<br/>Papillomavirus Infections--complications<br/>Repressor Proteins<br/>Semliki forest virus--genetics<br/>T-Lymphocytes, Cytotoxic--immunology<br/>Tumor Virus Infections--complications<br/>Uterine Cervical Neoplasms--prevention & control